Celsion CorpAdd to My Watchlist

CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 1.08
  • 0.01  -0.92%
    Today's Change
  • 1.09
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 10/25/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding26 million
Market Cap$28 million
Return on Equity ttm-87.81%
Last DividendCLSN:US does not pay a dividend
EPS: Year Actual ttm-0.864
EPS: Year Est. 12/16 ttm-0.833
EPS: Quarterly Actual 6/16 -0.19
EPS: Quarterly Est. 9/16 -0.20
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate25.36
Company Description
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Net Income$-22 million
Total Assets$49 million
Web Sitewww.celsion.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!